摘要
目的:探讨ER阳性乳腺癌和ER阴性乳腺癌的癌干/祖细胞生物学行为差异。方法:通过无血清培养方法获取富含乳腺癌癌干/祖细胞的非粘附乳腺球(mammospheres,MSs):体外无血清培养微球体细胞(mammospheres-derived cells,MSDCs)并绘制生长曲线,评价ER阳性乳腺癌和ER阴性乳腺癌MSDCs的增值能力;应用无血清连续克隆形成实验,计算MSDCs的MSs形成率(mammospheres forming efficiency,MSFE),比较两种MSDCs的自我更新能力;通过添加血清的培养方法诱导MSDCs分化,绘制生长曲线,比较两种MSDCs的分化能力:构建NOD/SCID小鼠模型,比较两种MSDCs移植瘤的生长差异。结果:ER阳性乳腺癌和ER阴性乳腺癌均能培养出MSs,ER阴性乳腺癌的MSs生长速度快,直径大,包含的细胞数量多;ER阴性乳腺癌的MSDCs具有更强的体外增殖能力、自我更新能力、分化能力和免疫缺陷动物体内致瘤能力。结论:ER阳性乳腺癌和ER阴性乳腺癌的癌干/祖细胞生物学行为存在明显的差异,两种类型的乳腺癌可能起源于不同的乳腺癌干/祖细胞。
Objective:To investigate the different biological behavior of ER-positive breast cancer and ER-negative breast cancer stem and progenitor cells derived from mammospheres.Method: The breast cancer stem and progenitor cells were enriched in suspension cultures as nonadherent mammospheres.The proliferative capacity of mammospheresderived cells(MSDCs)in serum-free media was assessed by determination growth curve.Serial clonal sphere formation assays were used to detect self-renewal capacity of MSDCs.The differentiation of MSDCs were induced by cultured them in media cotaining serum.The tumor formation ability of MSDCs was evaluated by implanting them into immune-deficient mice.Results: Cells isolated from ER-positive breast cancer and ER-negative breast cancer could grow in serum-free conditions as mammospheres.The mammospheres of ER-negative breast cancer grew faster,had a longer diameter and contained more cells than that of ER-positive breast cancer.The MSDCs of ER-negative breast cancer have greater proliferation capacity,self-renewal capacity,differentiation capacity in vitro and tumorigenicity in vivo compared to that of ER-positive breast cancer.Conclusion: The breast cancer stem and progenitor cells of ER-positive breast cancer and ER-negative have significantly different biological behavior and the two types of breast cancer may originate from different phenotype of stem and progenitor cells.
出处
《激光杂志》
CAS
CSCD
北大核心
2011年第3期55-57,共3页
Laser Journal
基金
重庆市卫生局医学科研计划项目(06-2-028)
关键词
乳腺肿瘤
雌激素受体
肿瘤干细胞
球型体
细胞
乳腺球
breast neoplasms
estrogen receptor
tumor stem cells
spheroids
cellular
mammosphere